EBOS cancels $3.75 billion Greencross purchase in surprise twist
Business media and market chatter had the New Zealand pharmaceutical and animal products giant, EBOS (ASX:EBO), poised to finalise a $3.75 billion acquisition of the Greencross animal care group.
Read More